Patent Assignment
Reel/Frame 063942/0001
Intellectual Property Security Agreement
Recorded: 2023-06-09
Pages: 15
Assignors
BAUSCH HEALTH IRELAND LIMITED
Executed: 2023-06-07
SOLTA MEDICAL IRELAND LIMITED
Executed: 2023-06-07
MEDICIS PHARMACEUTICAL CORPORATION
Executed: 2023-06-07
ORAPHARMA, INC.
Executed: 2023-06-07
SALIX PHARMACEUTICALS, INC.
Executed: 2023-06-07
SOLTA MEDICAL, INC.
Executed: 2023-06-07
PRECISION DERMATOLOGY, INC.
Executed: 2023-06-07
Assignee
BARCLAYS BANK PLC, AS COLLATERAL AGENT
745 SEVENTH AVENUE, NEW YORK, NEW YORK, 10019
Covered Properties
(29)
Temperature Controlled Heating Device and Method to Heat a Selected Area of a Biological Body
Ultrasonic Device and Method for Tissue Coagulation
Adaptive Control of Optical Pulses for Laser Medicine
Two-Dimensional Optical Scan System Using a Counter-Rotating Disk Scanner
Disposable Transducer Seal
Apparatus and Method to Apply Substances to Tissue
Apparatus and Methods for the Destruction of Adipose Tissue
Laser-induced transepidermal elimination of content by fractional photothermolysis
Optical System Having Aberrations for Transforming a Gaussian Laser-Beam Intensity Profile to a Quasi-Flat-Topped Intensity Profile in a Focal Region of the Optical System
Slip Ring Spacer and Method for Its Use
Optical Pattern Generator Using a Single Rotating Component
Ultrasonic Treatment of Adipose Tissue at Multiple Depths
Power Assisted Lipoplasty
Agonists of Guanylate Cyclase Useful For the Treatment of Gastrointestinal Disorders, Inflammation, Cancer and Other Disorders
Agonists of Guanylate Cyclase Useful for the Treatment of Hypercholesterolemia, Atherosclerosis, Coronary Heart Disease, Gallstone, Obesity and Other Cardiovascular Diseases
Ultra-Pure Agonists of Guanylate Cyclase C, Method of Making and Using Same
Agonists of Guanylate Cyclase Useful for the Treatment of Gastrointestinal Disorders, Inflammation, Cancer and Other Disorders
Ultra-Pure Agonists of Guanylate Cyclase C, Method of Making and Using Same
2 x 2 x 2 WEEK DOSING REGIMEN FOR TREATING ACTINIC KERATOSIS WITH PHARMACEUTICAL COMPOSITIONS FORMULATED WITH 3.75% IMIQUIMOD
Topical Pharmaceutical Compositions for Treating Skin Conditions
Ultra-Pure Agonists of Guanylate Cyclase C, Method of Making and Using Same
Anti-Infective Methods, Compositions, and Devices
Compositions and Methods for Treating Diseases of the Nail
Application:
17/092,473 →
Publication:
US 2021/0121572
Electrode Assemblies with Non-Contact Temperature Sensing for Thermal Measurements
Ultrasonic Probes for Producing Multiple Cavitation Volumes
Application:
17/909,028 →
Publication:
US 2023/0087566
Methods of Treating Covid-19 with Rifaximin
Application:
17/913,843 →
Publication:
US 2023/0116647
Hand Piece for Ultrasound Therapy Head
Patent:
629,525 →
Application:
29/363,081 →
Vented Tip
Patent:
970,741 →
Application:
29/763,116 →
Access Device
Patent:
959,428 →
Application:
29/789,564 →
Related Assignments
(25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
May 24, 2018
From: BAI, JUNCAI; ZHANG, RUOPING; JIA, JUN; ZHOU, JUNFENG
To: AMBIOPHARM, INC.
Reel/Frame 045896/0953 →
Assignment of Assignor's Interest
May 24, 2018
From: SHAILUBHAI, KUNWAR; COMISKEY, STEPHEN; FENG, RONG
To: SYNERGY PHARMACEUTICALS, INC.
Reel/Frame 045896/0984 →
Assignment of Assignor's Interest
May 24, 2018
From: AMBIOPHARM, INC.
To: SYNERGY PHARMACEUTICALS, INC.
Reel/Frame 045896/0971 →
Release of Security Interest
Mar 6, 2019
From: CRG SERVICING LLC
To: SYNERGY PHARMACEUTICALS INC.
Reel/Frame 048521/0005 →
Security Interest
Mar 11, 2019
From: BAUSCH HEALTH AMERICAS, INC.; BAUSCH & LOMB INCORPORATED; BAUSCH HEALTH US, LLC; SOLTA MEDICAL, INC.
To: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
Reel/Frame 048556/0758 →
Change of Name
Jun 5, 2019
From: MEDICIS TECHNOLOGIES CORPORATION
To: LIPOSONIX, INC.
Reel/Frame 049377/0234 →
Assignment of Assignor's Interest
Dec 17, 2019
From: SYNERGY PHARMACEUTICALS INC.
To: BAUSCH HEALTH IRELAND LIMITED
Reel/Frame 051305/0696 →
Assignment of Assignor's Interest
Jun 3, 2020
From: SYNERGY PHARMACEUTICALS, INC.
To: BAUSCH HEALTH IRELAND LIMITED
Reel/Frame 052827/0294 →
Assignment of Assignor's Interest
Jun 3, 2020
From: SHAILUBHAI, KUNWAR; JACOB, GARY S.
To: SYNERGY PHARMACEUTICALS, INC.
Reel/Frame 052827/0187 →
Assignment of Assignor's Interest
Apr 28, 2021
From: SYNERGY PHARMACEUTICALS, INC.
To: BAUSCH HEALTH IRELAND LIMITED
Reel/Frame 056067/0771 →
Change of Name
May 12, 2021
From: MEDICIS TECHNOLOGIES CORPORATION
To: LIPOSONIX, INC.
Reel/Frame 056228/0375 →
Merger
May 12, 2021
From: RELIANT TECHNOLOGIES, INC.
To: RELIANT TECHNOLOGIES, LLC
Reel/Frame 056218/0067 →
Merger
May 12, 2021
From: SOUND SURGICAL TECHNOLOGIES LLC
To: SOLTA MEDICAL, INC.
Reel/Frame 056214/0690 →
Merger
May 13, 2021
From: AESTHERA; LIPOSONIX, INC.
To: SOLTA MEDICAL, INC.
Reel/Frame 056227/0174 →
Merger
May 14, 2021
From: RELIANT TECHNOLOGIES, LLC
To: SOLTA MEDICAL, INC.
Reel/Frame 056244/0936 →
Merger
May 17, 2021
From: LIPOSONIX, INC.
To: SOLTA MEDICAL, INC.
Reel/Frame 056257/0362 →
Security Interest
Jun 8, 2021
From: BAUSCH & LOMB INCORPORATED; BAUSCH HEALTH US, LLC; SOLTA MEDICAL, INC.; MEDICIS PHARMACEUTICAL CORPORATION
To: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
Reel/Frame 056811/0814 →
Security Interest
Oct 5, 2021
From: BAUSCH & LOMB IRELAND LIMITED; BAUSCH HEALTH COMPANIES INC.; DR. GERHARD MANN CHEM.-PHARM. FABRIK GMBH; TECHNOLAS PERFECT VISION GMBH
To: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
Reel/Frame 057821/0800 →
Assignment of Assignor's Interest
Dec 27, 2021
From: SYNERGY PHARMACEUTICALS, INC.
To: BAUSCH HEALTH IRELAND LIMITED
Reel/Frame 058481/0814 →
Security Agreement
Feb 10, 2022
From: BAUSCH & LOMB INCORPORATED; BAUSCH HEALTH US, LLC; SOLTA MEDICAL, INC.; MEDICIS PHARMACEUTICAL CORPORATION
To: THE BANK OF NEW YORK MELLON
Reel/Frame 059121/0001 →
Merger
May 10, 2022
From: LIPOSONIX, INC.
To: SOLTA MEDICAL, INC.
Reel/Frame 059878/0170 →
Security Interest
Jun 13, 2022
From: BAUSCH HEALTH COMPANIES INC.; BAUSCH HEALTH, CANADA INC.; BAUSCH HEALTH IRELAND LIMITED; SOLTA MEDICAL IRELAND LIMITED
To: THE BANK OF NEW YORK MELLON
Reel/Frame 060346/0705 →
Security Agreement (First Lien)
Oct 4, 2022
From: BAUSCH HEALTH US, LLC; BAUSCH HEALTH AMERICAS, INC.; MEDICIS PHARMACEUTICAL CORPORATION; ORAPHARMA, INC.
To: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
Reel/Frame 061595/0066 →
Security Agreement (Second Lien)
Oct 5, 2022
From: BAUSCH HEALTH US, LLC; BAUSCH HEALTH AMERICAS, INC.; MEDICIS PHARMACEUTICAL CORPORATION; ORAPHARMA, INC.
To: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
Reel/Frame 061606/0468 →
Security Agreement (Second Lien)
Nov 4, 2022
From: BAUSCH HEALTH COMPANIES INC.; BAUSCH HEALTH IRELAND LIMITED; SOLTA MEDICAL IRELAND LIMITED
To: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
Reel/Frame 062078/0276 →